Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

OrganiGram Holdings stock

OGI.TO
CA68620P1018

Price

2.03
Today +/-
-0.02
Today %
-1.71 %
P

OrganiGram Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the OrganiGram Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the OrganiGram Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the OrganiGram Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze OrganiGram Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

OrganiGram Holdings Stock Price History

DateOrganiGram Holdings Price
11/19/20242.03 undefined
11/18/20242.07 undefined
11/15/20242.04 undefined
11/14/20242.10 undefined
11/13/20242.22 undefined
11/12/20242.22 undefined
11/11/20242.16 undefined
11/8/20242.20 undefined
11/7/20242.28 undefined
11/6/20242.34 undefined
11/5/20242.56 undefined
11/4/20242.51 undefined
11/1/20242.41 undefined
10/31/20242.36 undefined
10/30/20242.46 undefined
10/29/20242.55 undefined
10/28/20242.58 undefined
10/25/20242.60 undefined
10/24/20242.50 undefined
10/23/20242.50 undefined
10/22/20242.58 undefined

OrganiGram Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into OrganiGram Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OrganiGram Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OrganiGram Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of OrganiGram Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into OrganiGram Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing OrganiGram Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OrganiGram Holdings’s growth potential.

OrganiGram Holdings Revenue, EBIT and net profit per share

DateOrganiGram Holdings RevenueOrganiGram Holdings EBITOrganiGram Holdings Net Income
2030e872.49 M undefined0 undefined0 undefined
2029e751.97 M undefined0 undefined0 undefined
2028e543.8 M undefined0 undefined0 undefined
2027e307.23 M undefined27.8 M undefined-792,558.85 undefined
2026e206.7 M undefined-5.05 M undefined-2.74 M undefined
2025e185.06 M undefined-16.08 M undefined-10.42 M undefined
2024e162.28 M undefined-39.29 M undefined-46.52 M undefined
2023161.6 M undefined-121.8 M undefined-248.6 M undefined
2022145.8 M undefined-78.9 M undefined-14.3 M undefined
202179.2 M undefined-77 M undefined-130.7 M undefined
202086.8 M undefined-61.3 M undefined-136.2 M undefined
201980.4 M undefined-4.5 M undefined-9.5 M undefined
201812.4 M undefined-9.6 M undefined20.5 M undefined
20175.4 M undefined-9.7 M undefined-10.9 M undefined
20166.1 M undefined-800,000 undefined800,000 undefined
20151 M undefined-2.3 M undefined-1.3 M undefined
20140 undefined0 undefined-200,000 undefined
20130 undefined-400,000 undefined-400,000 undefined
20120 undefined-100,000 undefined-100,000 undefined
20110 undefined-100,000 undefined-100,000 undefined
20100 undefined-80,000 undefined-80,000 undefined

OrganiGram Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
0000016512808679145161162185206307543751872
------500.00-16.67140.00566.677.50-8.1483.5411.030.6214.2011.3549.0376.8738.3116.11
------3,100.0050.00-20.0041.6746.25-13.95-30.38-5.52-19.25-19.14-16.76-15.05-10.10-5.71-4.13-3.56
0000003-1537-12-24-8-310000000
00000-10-1020-9-136-130-14-248-46-10-20000
---------300.00-145.001,411.11-4.41-89.231,671.43-81.45-78.26-80.00----
7.331.81.51.81.813.114.724.331.735.243.26477.281.30000000
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The OrganiGram Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the OrganiGram Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20102011201220132014201520162017201820192020202120222023
                           
0.20.30.20.15.71.532.634130.147.974.7183.698.633.9
00000.20.81.60.50.811.611.120.243.927.5
00000003.62.95.95.91.12.52.7
0000013.92.664.8113.871.848.868.381
00000.21.42.544.617.16.778.411
0.20.30.20.16.14.740.644.7203.2196.3170.2260.7221.7156.1
0.10.20.202.59.613.245.398.6219247.4235.9259.899
00000000011.176.17.114.3
00000000000000
0000000001.51.82.714.310.6
00000002.300014.3420
00000000.50.70.68.734.332.418.5
0.10.20.202.59.613.248.199.3232.2264.9293.3355.6142.4
0.30.50.40.18.614.353.892.8302.5428.5435.1554577.3298.5
                           
0.30.60.60.615.516.85199.7157.8318.1420.7730.8769.7776.9
00000000000000
0-0.2-0.4-0.6-7.9-8.9-6.7-16.726.88.9-121.2-250.9-261.6-505.1
0000000000100-100-100-200
00000000000000
0.30.40.207.67.944.383184.6327299.6479.8508271.6
000.10.11.11.52.16.310.840.416.422.540.920
00000000000000
000000000.1002.813.41.3
00000000000000
000000.30.30.40.43.512.71.111.1
000.10.11.11.82.46.711.343.929.126.455.322.4
000004.67.23.198.746.1106.34.92.43.6
00000000810.5003.60
0000000001.10.243.17.80.8
000004.67.23.1106.757.7106.54813.84.4
000.10.11.16.49.69.8118101.6135.674.469.126.8
0.30.40.30.18.714.353.992.8302.6428.6435.2554.2577.1298.4
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of OrganiGram Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand OrganiGram Holdings's financial health and stability.

Assets

OrganiGram Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that OrganiGram Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of OrganiGram Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into OrganiGram Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201020112012201320142014201520162017201820192020202120222023
00000-8-10-1022-9-136-130-14-248
0000000013817312426
00000000053-10000
000000-1-3-2-46-572924-22-5
0000060022185446-23189
000000000474200
000000000000000
00000-1-2-1-9-12-35-45-28-36-38
00000-1-7-4-31-56-110-78-12-48-30
00000-1-7-27-39-98-46-138-115444
0000000-22-8-4163-59-1029235
000000000000000
00000042-11074663-51-10
00000913745643510122860
000008637401637416017450
--------2.00-2.00-7.00-7.00-4.00-2.00--
000000000000000
000005-48-753-7-223013-34
-0.14-0.14-0.17-0.2-0.02-2.65-10.29-6.19-40.44-69.25-145.37-123.78-40.92-84.99-69.21
000000000000000

OrganiGram Holdings stock margins

The OrganiGram Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OrganiGram Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OrganiGram Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the OrganiGram Holdings's sales revenue. A higher gross margin percentage indicates that the OrganiGram Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the OrganiGram Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the OrganiGram Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OrganiGram Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OrganiGram Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OrganiGram Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

OrganiGram Holdings Margin History

OrganiGram Holdings Gross marginOrganiGram Holdings Profit marginOrganiGram Holdings EBIT marginOrganiGram Holdings Profit margin
2030e-19.18 %0 %0 %
2029e-19.18 %0 %0 %
2028e-19.18 %0 %0 %
2027e-19.18 %9.05 %-0.26 %
2026e-19.18 %-2.44 %-1.33 %
2025e-19.18 %-8.69 %-5.63 %
2024e-19.18 %-24.21 %-28.67 %
2023-19.18 %-75.37 %-153.84 %
2022-5.76 %-54.12 %-9.81 %
2021-30.81 %-97.22 %-165.03 %
2020-13.94 %-70.62 %-156.91 %
201947.14 %-5.6 %-11.82 %
201845.16 %-77.42 %165.32 %
2017-35.19 %-179.63 %-201.85 %
201654.1 %-13.11 %13.11 %
201520 %-230 %-130 %
2014-19.18 %0 %0 %
2013-19.18 %0 %0 %
2012-19.18 %0 %0 %
2011-19.18 %0 %0 %
2010-19.18 %0 %0 %

OrganiGram Holdings Stock Sales Revenue, EBIT, Earnings per Share

The OrganiGram Holdings earnings per share therefore indicates how much revenue OrganiGram Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OrganiGram Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OrganiGram Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OrganiGram Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OrganiGram Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

OrganiGram Holdings Revenue, EBIT and net profit per share

DateOrganiGram Holdings Sales per ShareOrganiGram Holdings EBIT per shareOrganiGram Holdings Earnings per Share
2030e8.04 undefined0 undefined0 undefined
2029e6.93 undefined0 undefined0 undefined
2028e5.01 undefined0 undefined0 undefined
2027e2.83 undefined0 undefined-0.01 undefined
2026e1.9 undefined0 undefined-0.03 undefined
2025e1.7 undefined0 undefined-0.1 undefined
2024e1.49 undefined0 undefined-0.43 undefined
20231.99 undefined-1.5 undefined-3.06 undefined
20221.89 undefined-1.02 undefined-0.19 undefined
20211.24 undefined-1.2 undefined-2.04 undefined
20202.01 undefined-1.42 undefined-3.15 undefined
20192.28 undefined-0.13 undefined-0.27 undefined
20180.39 undefined-0.3 undefined0.65 undefined
20170.22 undefined-0.4 undefined-0.45 undefined
20160.41 undefined-0.05 undefined0.05 undefined
20150.08 undefined-0.18 undefined-0.1 undefined
20140 undefined0 undefined-0.11 undefined
20130 undefined-0.22 undefined-0.22 undefined
20120 undefined-0.07 undefined-0.07 undefined
20110 undefined-0.06 undefined-0.06 undefined
20100 undefined-0.01 undefined-0.01 undefined

OrganiGram Holdings business model

OrganiGram Holdings Inc is a company dedicated to the production and marketing of cannabis products. The company was founded in 2013 and is based in Moncton, New Brunswick. It has been listed on the Toronto Stock Exchange since 2014. OrganiGram Holdings is one of the most popular companies on Eulerpool.com.

OrganiGram Holdings SWOT Analysis

Strengths

1. Strong brand reputation: OrganiGram Holdings Inc has established itself as a reputable and trusted player in the cannabis industry.

2. High-quality product portfolio: The company offers a diverse range of premium cannabis products known for their consistency and efficacy.

3. Efficient production capabilities: OrganiGram has invested in advanced cultivation methods and technology, leading to high yields and cost efficiencies.

Weaknesses

1. Limited distribution network: OrganiGram's distribution network is relatively smaller compared to some of its competitors, impacting its market reach.

2. Dependence on the Canadian market: The company primarily operates in Canada, making it vulnerable to changes in the Canadian cannabis industry and regulations.

3. Financial constraints: OrganiGram has faced financial challenges in the past, which may hinder its ability to invest in expansion and innovation.

Opportunities

1. Growing global cannabis market: The legalization of cannabis in various countries presents an opportunity for OrganiGram to expand its presence internationally.

2. Diversification into new product categories: The company can explore diversifying its product offerings to include cannabis-infused beverages, edibles, and wellness products.

3. Strategic partnerships: Collaborations with established brands or industry leaders can help OrganiGram strengthen its distribution network and gain market share.

Threats

1. Intense competition: The cannabis industry is highly competitive, with numerous players vying for market share, which may impact OrganiGram's profitability.

2. Regulatory uncertainties: Changes in cannabis regulations and government policies can pose challenges and disrupt business operations for OrganiGram.

3. Health concerns and stigma: Negative perceptions surrounding cannabis use and potential health risks may affect consumer demand and overall market growth.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OrganiGram Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

OrganiGram Holdings historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OrganiGram Holdings shares outstanding

The number of shares was OrganiGram Holdings in 2023 — This indicates how many shares 81.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OrganiGram Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OrganiGram Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OrganiGram Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OrganiGram Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

OrganiGram Holdings stock splits

In OrganiGram Holdings's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for OrganiGram Holdings.

OrganiGram Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.07 0.03  (136.78 %)2024 Q3
3/31/2024-0.09 -0.26  (-175.72 %)2024 Q2
9/30/2023-0.14 -0.13  (7.97 %)2023 Q4
6/30/2023-0.06 -0.68  (-972.9 %)2023 Q3
3/31/2023-0.07 -0.1  (-35.79 %)2023 Q2
12/31/2022-0.03 0.07  (324.42 %)2023 Q1
9/30/2022-0.08 -0.08  (0.99 %)2022 Q4
6/30/2022-0.07 -0.36  (-409.19 %)2022 Q3
3/31/2022-0.09 -0.05  (45.14 %)2022 Q2
12/31/2021-0.13 -0.02  (87.63 %)2022 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the OrganiGram Holdings stock

Eulerpool World ESG Rating (EESG©)

46/ 100

🌱 Environment

22

👫 Social

48

🏛️ Governance

67

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

OrganiGram Holdings shareholders

%
Name
Stocks
Change
Date
30.00004 % British American Tobacco plc32,571,9424,429,7408/30/2024
1.69332 % ETF Managers Group, LLC1,838,4831,838,4833/31/2023
1.65697 % Tidal Investments LLC1,799,01761,1416/30/2024
0.92116 % AdvisorShares Investments, LLC1,000,126105,4686/30/2024
0.75244 % Renaissance Technologies LLC816,948236,7006/30/2024
0.51265 % Global X Investments Canada Inc.556,598-74,8949/30/2024
0.42515 % BMO Capital Markets (US)461,5932966/30/2024
0.23640 % Dimensional Fund Advisors, L.P.256,66206/30/2024
0.23285 % Baader Bank AG252,814-389/30/2024
0.23026 % BN & Partners Deutschland AG250,00008/31/2024
1
2
3
4
5
...
10

OrganiGram Holdings Executives and Management Board

Ms. Beena Goldenberg(61)
OrganiGram Holdings Chief Executive Officer, Director (since 2021)
Compensation 761,295
Mr. Timothy Emberg
OrganiGram Holdings Chief Commercial Officer
Compensation 453,704
Ms. Helen Martin
OrganiGram Holdings Chief Legal Officer, Corporate Secretary
Compensation 446,686
Mr. Peter Amirault(63)
OrganiGram Holdings Independent Chairman of the Board (since 2016)
Compensation 236,917
Mr. Dexter John(54)
OrganiGram Holdings Independent Director
Compensation 180,000
1
2
3
4

Most common questions regarding OrganiGram Holdings

What values and corporate philosophy does OrganiGram Holdings represent?

OrganiGram Holdings Inc represents a commitment to excellence, sustainability, and innovation in the cannabis industry. With a focus on producing high-quality, organic cannabis products, OrganiGram prioritizes the well-being of its customers and the environment. The company's corporate philosophy is centered around providing safe and reliable cannabis options, while also valuing social responsibility and community engagement. OrganiGram is dedicated to cultivating relationships with its customers, understanding their needs, and consistently delivering superior products. By upholding these core values, OrganiGram Holdings Inc strives to be a trusted leader in the cannabis market.

In which countries and regions is OrganiGram Holdings primarily present?

OrganiGram Holdings Inc is primarily present in Canada.

What significant milestones has the company OrganiGram Holdings achieved?

OrganiGram Holdings Inc has achieved several significant milestones in its operations. Firstly, the company expanded its production capacity through the completion of Phase 3 expansion in 2019. This expansion enabled OrganiGram to increase its annual cannabis production capacity to 76,000 kilograms. Additionally, OrganiGram has successfully developed innovative cannabis derivative products, such as cannabis-infused chocolates and powdered beverages. Moreover, the company has received various certifications, including organic certification by Pro-Cert, which further demonstrates its commitment to producing high-quality and sustainable cannabis products. By focusing on expansion, innovation, and quality, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

What is the history and background of the company OrganiGram Holdings?

OrganiGram Holdings Inc is a Canadian cannabis company that was founded in 2013. It is a licensed producer of medical marijuana, with cultivation facilities located in Moncton, New Brunswick. The company's mission is to provide high-quality, organically-grown cannabis products to both medical and adult-use recreational consumers. OrganiGram Holdings Inc has a strong focus on innovation and sustainability, employing advanced growing techniques and operating under strict quality control measures. With a diverse product line and a commitment to customer satisfaction, OrganiGram Holdings Inc has established itself as a leading player in the cannabis industry.

Who are the main competitors of OrganiGram Holdings in the market?

The main competitors of OrganiGram Holdings Inc in the market include companies such as Canopy Growth Corporation and Aurora Cannabis Inc.

In which industries is OrganiGram Holdings primarily active?

OrganiGram Holdings Inc is primarily active in the cannabis industry.

What is the business model of OrganiGram Holdings?

The business model of OrganiGram Holdings Inc is focused on the cultivation, production, and distribution of high-quality cannabis products. As a leading Canadian licensed producer, OrganiGram operates state-of-the-art indoor facilities to ensure consistent, premium cannabis cultivation. The company's business model revolves around their commitment to innovation, sustainability, and customer satisfaction. By leveraging advanced growing techniques, strategic partnerships, and a diverse product portfolio, OrganiGram aims to cater to both medical and adult-use recreational cannabis markets. With a customer-centric approach and ongoing research and development, OrganiGram Holdings Inc strives to deliver safe, reliable, and exceptional cannabis experiences while contributing to the overall growth of the industry.

What is the P/E ratio of OrganiGram Holdings 2024?

The OrganiGram Holdings P/E ratio is -3.55.

What is the P/S ratio of OrganiGram Holdings 2024?

The OrganiGram Holdings P/S ratio is 1.02.

What is the Quality Investing of OrganiGram Holdings?

The Quality Investing for OrganiGram Holdings is 5/10.

What is the revenue of OrganiGram Holdings 2024?

The expected OrganiGram Holdings revenue is 162.28 M CAD.

How high is the profit of OrganiGram Holdings 2024?

The expected OrganiGram Holdings profit is -46.52 M CAD.

What is the business model of OrganiGram Holdings

OrganiGram Holdings Inc. is a Canadian company specializing in the production, distribution, and marketing of medical cannabis. The business model of OrganiGram includes a wide range of products that can be used for a variety of medical conditions and symptoms. OrganiGram's main focus is the production of cannabis flowers rich in cannabinoids such as THC and CBD. These flowers are offered in different formats, including dried, pressed buds and cured flowers that can be used in capsules or vaporizers. OrganiGram also offers various strains of cannabis flowers specifically developed for different medical conditions or symptoms. In addition to cannabis flowers, OrganiGram also produces various other cannabis products, such as oils and extracts. These products are made from the flowers of the cannabis plant and provide a convenient way to harness the health benefits of cannabis without actually having to smoke or vaporize it. OrganiGram also offers vaporizable oils specifically developed for medical purposes. Another product segment of OrganiGram includes edible products made from cannabis. These include chocolates, candies, and beverages, all of which contain a controlled amount of cannabinoids and are specially developed for medical purposes. OrganiGram also offers a variety of accessories and other products specifically designed for the use of medical cannabis, including vaporizers, capsules, rolling papers, and other utensils suitable for use with OrganiGram's cannabis products. To produce and distribute these products, OrganiGram has developed a comprehensive cultivation system that ensures the flowers and plants are of the highest quality. The company utilizes state-of-the-art technology and methods to ensure the purity, efficacy, and quality of its products. In addition, OrganiGram operates a wide range of online and retail activities to market and sell its products. The company uses a variety of traditional and digital marketing channels to raise awareness of its brand and promote awareness of the health benefits of medical cannabis. Overall, OrganiGram's business model is very diverse and includes a variety of products and services specifically tailored to the use of medical cannabis. Through its innovative research and development, advanced cultivation system, and comprehensive marketing strategy, OrganiGram is able to serve a growing customer base seeking safe and effective products for symptom relief and disease management.

What is the OrganiGram Holdings dividend?

OrganiGram Holdings pays a dividend of 0 CAD distributed over payouts per year.

How often does OrganiGram Holdings pay dividends?

The dividend cannot currently be calculated for OrganiGram Holdings or the company does not pay out a dividend.

What is the OrganiGram Holdings ISIN?

The ISIN of OrganiGram Holdings is CA68620P1018.

What is the OrganiGram Holdings ticker?

The ticker of OrganiGram Holdings is OGI.TO.

How much dividend does OrganiGram Holdings pay?

Over the past 12 months, OrganiGram Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OrganiGram Holdings is expected to pay a dividend of 0 CAD.

What is the dividend yield of OrganiGram Holdings?

The current dividend yield of OrganiGram Holdings is .

When does OrganiGram Holdings pay dividends?

OrganiGram Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OrganiGram Holdings?

OrganiGram Holdings paid dividends every year for the past 0 years.

What is the dividend of OrganiGram Holdings?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OrganiGram Holdings located?

OrganiGram Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von OrganiGram Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OrganiGram Holdings from 11/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did OrganiGram Holdings pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of OrganiGram Holdings in the year 2023?

In the year 2023, OrganiGram Holdings distributed 0 CAD as dividends.

In which currency does OrganiGram Holdings pay out the dividend?

The dividends of OrganiGram Holdings are distributed in CAD.

All fundamentals about OrganiGram Holdings

Our stock analysis for OrganiGram Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OrganiGram Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.